Clinical Trial Update: Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing calfactant and poractant alfa delivered via a less invasive technique in preterm infants with respiratory distress syndrome; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Calfactant (calfactant)
• Poractant alfa (poractant alfa)

Snippet

Sponsor: Uludag University | Conditions: Respiratory Distress Syndrome in Premature Infants, Respiratory Distress Syndrome (RDS) | Phase 4 | Status: NOT_YET_RECRUITING